Dyno Therapeutics

Developer of a biotechnology platform designed to offer technologies for novel gene therapies. The company's platform uses AI and combines next-generation DNA synthesis of Adeno-Associated Virus capsids with sequencing and machine learning, enabling medical researchers to access novel vectors that allow safe, efficient, and targeted in vivo delivery for new gene therapies.

Lux Capital

Andreessen Horowitz

🤖 AI/ML

🏥 Healthcare